Methods and Compositions for RAF Kinase Mediated Diseases
申请人:ARIAD Pharmaceuticals, Inc.
公开号:US20150105377A1
公开(公告)日:2015-04-16
The invention discloses methods and compositions for treating or preventing RAF kinase mediated diseases or conditions by administering a compound of Formula 1: or a pharmaceutically acceptable salt, solvate or hydrate thereof, wherein the variables are defined as herein.
A para-selective CH amidation of simplearenes with nitriles has been developed. By increasing the amount of arenes, a further meta-selective CH arylation of the produced amides occurred. Both steric and electronic effects are utilized to control the selectivity, resulting in only para-selectiveamidation products. The readily available nitriles as amidation reagents instead of amides makes the synthesis